[go: up one dir, main page]

AU692598B2 - Methods of maintaining teeth and oral bone - Google Patents

Methods of maintaining teeth and oral bone

Info

Publication number
AU692598B2
AU692598B2 AU34088/95A AU3408895A AU692598B2 AU 692598 B2 AU692598 B2 AU 692598B2 AU 34088/95 A AU34088/95 A AU 34088/95A AU 3408895 A AU3408895 A AU 3408895A AU 692598 B2 AU692598 B2 AU 692598B2
Authority
AU
Australia
Prior art keywords
oral
bone
compound
tooth
teeth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34088/95A
Other languages
English (en)
Other versions
AU3408895A (en
Inventor
William Lockridge Sales
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3408895A publication Critical patent/AU3408895A/en
Application granted granted Critical
Publication of AU692598B2 publication Critical patent/AU692598B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU34088/95A 1994-08-22 1995-08-21 Methods of maintaining teeth and oral bone Ceased AU692598B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29423794A 1994-08-22 1994-08-22
US294237 1994-08-22
PCT/US1995/010582 WO1996005829A1 (en) 1994-08-22 1995-08-21 Methods of maintaining teeth and oral bone

Publications (2)

Publication Number Publication Date
AU3408895A AU3408895A (en) 1996-03-14
AU692598B2 true AU692598B2 (en) 1998-06-11

Family

ID=23132491

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34088/95A Ceased AU692598B2 (en) 1994-08-22 1995-08-21 Methods of maintaining teeth and oral bone

Country Status (14)

Country Link
EP (1) EP0769946A4 (sv)
JP (1) JPH10504573A (sv)
KR (1) KR970705386A (sv)
AU (1) AU692598B2 (sv)
CA (1) CA2198108A1 (sv)
CZ (1) CZ52197A3 (sv)
FI (1) FI970713A (sv)
HU (1) HUT76891A (sv)
IL (1) IL115017A0 (sv)
MX (1) MX9701331A (sv)
NO (1) NO970784D0 (sv)
WO (1) WO1996005829A1 (sv)
YU (1) YU55495A (sv)
ZA (1) ZA956987B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0584952A1 (en) * 1992-07-28 1994-03-02 Eli Lilly And Company Improvements in or relating to benzothiophenes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0584952A1 (en) * 1992-07-28 1994-03-02 Eli Lilly And Company Improvements in or relating to benzothiophenes

Also Published As

Publication number Publication date
JPH10504573A (ja) 1998-05-06
FI970713A0 (sv) 1997-02-20
YU55495A (sh) 1998-07-10
MX9701331A (es) 1997-05-31
CZ52197A3 (en) 1997-08-13
ZA956987B (en) 1997-02-21
CA2198108A1 (en) 1996-02-29
EP0769946A1 (en) 1997-05-02
HUT76891A (en) 1997-12-29
FI970713A (sv) 1997-02-20
NO970784L (no) 1997-02-20
AU3408895A (en) 1996-03-14
IL115017A0 (en) 1995-12-08
EP0769946A4 (en) 1997-11-05
KR970705386A (ko) 1997-10-09
WO1996005829A1 (en) 1996-02-29
NO970784D0 (no) 1997-02-20

Similar Documents

Publication Publication Date Title
AU670394B2 (en) Methods for the treatment of peri-menopausal syndrome
US5616313A (en) Method for treating gingival and periodontal tissues
US8303938B2 (en) Anti-calculus dental composition
CA2198016A1 (en) Methods of inhibiting ulcerative mucositis
US20070292363A1 (en) Method for prevention and treatment of periodontal disease
WO2002089755A1 (en) Cationic antibacterial dentifrice exhibiting superior foaming properties
AU692598B2 (en) Methods of maintaining teeth and oral bone
EP0659414B1 (en) Inhibition of hirsutism and alopecia in women
US11419889B2 (en) Oral compositions for post-dental implants
KR100308247B1 (ko) 구강 청정용 조성물
Coessens et al. Plaque-inhibiting effect of bioadhesive mucosal tablets containing chlorhexidine in a 4-day plaque regrowth model
JPH10504578A (ja) 骨治癒および骨折修復法
RU2147222C1 (ru) Средство для ухода за полостью рта
EP0772438B1 (en) Use of benzothiophenes for the preparation of a medicament for reducing scarring in wound healing
EP1274395A1 (en) New formulations for the removal of dental plaque, tartar and dental stains
CN1161648A (zh) 保养牙齿及口腔骨骼的方法
Gaffar Oral-care products
WO2006110183A2 (en) Dental formulation

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired